[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 110, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 42, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 60, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Franco  Valle", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 673659, "exercisedValue": 0, "unexercisedValue": 687866}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 64, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 53, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1719792000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.46, "open": 5.59, "dayLow": 5.33, "dayHigh": 5.63, "regularMarketPreviousClose": 5.46, "regularMarketOpen": 5.59, "regularMarketDayLow": 5.33, "regularMarketDayHigh": 5.63, "beta": -0.545, "forwardPE": -1.610465, "volume": 312139, "regularMarketVolume": 312139, "averageVolume": 1287529, "averageVolume10days": 416160, "averageDailyVolume10Day": 416160, "bid": 5.52, "ask": 5.56, "bidSize": 200, "askSize": 200, "marketCap": 199133088, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 23.03, "fiftyDayAverage": 7.082, "twoHundredDayAverage": 12.1552, "currency": "USD", "enterpriseValue": 65306996, "floatShares": 19450333, "sharesOutstanding": 35944600, "sharesShort": 7903014, "sharesShortPriorMonth": 11790430, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.2199, "heldPercentInsiders": 0.25144, "heldPercentInstitutions": 0.76658, "shortRatio": 5.96, "shortPercentOfFloat": 0.35990003, "impliedSharesOutstanding": 35944600, "bookValue": 3.766, "priceToBook": 1.4710568, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -127265000, "trailingEps": -3.55, "forwardEps": -3.44, "enterpriseToEbitda": -0.482, "52WeekChange": -0.75101125, "SandP52WeekChange": 0.18961596, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.54, "targetHighPrice": 60.0, "targetLowPrice": 5.0, "targetMeanPrice": 26.0, "targetMedianPrice": 18.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 144918000, "totalCashPerShare": 4.032, "ebitda": -135520992, "totalDebt": 11092000, "quickRatio": 5.738, "currentRatio": 5.843, "debtToEquity": 8.197, "returnOnAssets": -0.60987, "returnOnEquity": -1.1652, "freeCashflow": -62755876, "operatingCashflow": -104578000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-29"}]